Michael A. Metzger - 16 Jul 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Issuer symbol
SNDX
Transactions as of
16 Jul 2025
Net transactions value
-$69,953
Form type
4
Filing time
18 Jul 2025, 16:30:04 UTC
Previous filing
02 Apr 2025
Next filing
08 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Metzger Michael A Chief Executive Officer, Director C/O SYNDAX PHARMACEUTICALS, INC., 730 3RD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger 18 Jul 2025 0001507220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Sale $69,953 -7,534 -2.5% $9.28 298,661 16 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.